Q/C Technologies, Inc.

Technology · Computer Hardware · United States

Last price 0.4404 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.61M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including ...